| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,250,000,000 |
| Market
Cap: |
100.60(B) |
| Last
Volume: |
14,535,649 |
Avg
Vol: |
11,963,293 |
| 52
Week Range: |
$43.67 - $69.08 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.3 |
| Insider 3/6 Months : 11.9 |
|
| Guru Rank Number : 97 |
| Guru Rank Value : 8.6 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
13,571 |
13,571 |
13,571 |
| Total Buy Value |
$0 |
$672,994 |
$672,994 |
$672,994 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
3 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
18,718 |
681,397 |
| Total Sell Value |
$0 |
$0 |
$1,146,397 |
$49,727,684 |
| Total People Sold |
0 |
0 |
2 |
6 |
| Total Sell Transactions |
0 |
0 |
2 |
12 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Judge Ann Powell |
SVP, Global Human Resources |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,991) |
67,875 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2019-02-28 |
4 |
D |
$51.86 |
$5,697,028 |
D/D |
(109,854) |
524,624 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2019-02-28 |
4 |
OE |
$17.51 |
$2,974,826 |
D/D |
169,893 |
634,478 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2019-02-28 |
4 |
D |
$51.93 |
$1,548,189 |
D/D |
(29,813) |
362,877 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2019-02-28 |
4 |
OE |
$17.51 |
$925,999 |
D/D |
52,884 |
392,690 |
|
- |
|
| Boerner Christopher S. |
EVP, Chief Commercial Officer |
• – – |
2019-02-02 |
4 |
D |
$49.89 |
$79,375 |
D/D |
(1,591) |
2,874 |
|
- |
|
| Boerner Christopher S. |
EVP, Chief Commercial Officer |
• – – |
2019-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,465 |
4,465 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4/A |
D |
$53.46 |
$145,197 |
D/D |
(2,716) |
339,806 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4/A |
OE |
$0.00 |
$0 |
D/D |
6,401 |
342,522 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4 |
D |
$53.46 |
$145,197 |
D/D |
(2,716) |
203,401 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,401 |
206,117 |
|
- |
|
| Biondi Paul |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4/A |
D |
$62.80 |
$18,338 |
D/D |
(292) |
1,041 |
|
- |
|
| Biondi Paul |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4/A |
OE |
$0.00 |
$0 |
D/D |
592 |
1,333 |
|
- |
|
| Biondi Paul |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4 |
D |
$62.80 |
$18,338 |
D/D |
(292) |
300 |
|
- |
|
| Biondi Paul |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
592 |
592 |
|
- |
|
| Dubow Adam |
Chief Compliance & Ethics Offi |
• – – |
2018-09-03 |
4 |
D |
$60.55 |
$16,530 |
D/D |
(273) |
15,222 |
|
- |
|
| Dubow Adam |
Chief Compliance & Ethics Offi |
• – – |
2018-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
797 |
15,495 |
|
- |
|
| Santiago Karen Murphy |
Controller |
• – – |
2018-09-01 |
4 |
D |
$60.55 |
$13,321 |
D/D |
(220) |
3,837 |
|
- |
|
| Santiago Karen Murphy |
Controller |
• – – |
2018-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
641 |
4,057 |
|
- |
|
| Gordon Murdo |
EVP, Chief Commercial Officer |
• – – |
2018-08-01 |
4 |
D |
$59.62 |
$44,357 |
D/D |
(744) |
49,424 |
|
- |
|
| Gordon Murdo |
EVP, Chief Commercial Officer |
• – – |
2018-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,510 |
50,168 |
|
- |
|
| Biondi Paul |
SVP, Head of Strategy & BD |
• – – |
2018-07-01 |
4 |
D |
$55.34 |
$39,845 |
D/D |
(720) |
741 |
|
- |
|
| Biondi Paul |
SVP, Head of Strategy & BD |
• – – |
2018-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,461 |
1,461 |
|
- |
|
| Caforio Giovanni |
Chairman and CEO |
• • – |
2018-05-05 |
4 |
D |
$51.33 |
$161,484 |
D/D |
(3,146) |
288,033 |
|
- |
|
| Caforio Giovanni |
Chairman and CEO |
• • – |
2018-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,643) |
291,179 |
|
- |
|
2225 Records found
|
|
Page 19 of 89 |
|
|
0.35 (0.78%) 
